Huitema, Alwin D.R.
Princess Máxima Center for Pediatric Oncology,
Netherlands
2025 Rank: 209985
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1622 out of 157499 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 209985 | 204090 |
| Total Cites | 1356 | 1620 |
| H-index | 15 | 17 |
| Hm-index | 6 | 7 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 23 | 23 |
| Total Cites to Single+First Authored Papers | 5 | 5 |
| Number of Single+First+Last Authored Papers | 188 | 188 |
| Total Cites to Single+First+Last Authored Papers | 308 | 355 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1105 | 1220 |
| Ratio of Total Citations to Distinct Citing Papers | 1.23 | 1.33 |
| Self-Citation Percentage |
16.30%
|
|
Huitema, Alwin D.R.
The Netherlands Cancer Institute,
Netherlands
2024 Rank: 167968
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1218 out of 148458 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 167968 | 173418 |
| Total Cites | 1297 | 1511 |
| H-index | 15 | 16 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 23 | 23 |
| Total Cites to Single+First Authored Papers | 8 | 9 |
| Number of Single+First+Last Authored Papers | 179 | 179 |
| Total Cites to Single+First+Last Authored Papers | 322 | 371 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1050 | 1133 |
| Ratio of Total Citations to Distinct Citing Papers | 1.24 | 1.33 |
| Self-Citation Percentage |
14.16%
|
|
Huitema, Alwin D.R.
The Netherlands Cancer Institute,
Netherlands
2023 Rank: 202676
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1555 out of 140593 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 202676 | 197069 |
| Total Cites | 1159 | 1359 |
| H-index | 13 | 14 |
| Hm-index | 5 | 6 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 23 | 23 |
| Total Cites to Single+First Authored Papers | 9 | 10 |
| Number of Single+First+Last Authored Papers | 171 | 171 |
| Total Cites to Single+First+Last Authored Papers | 312 | 358 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 945 | 1043 |
| Ratio of Total Citations to Distinct Citing Papers | 1.23 | 1.30 |
| Self-Citation Percentage |
14.72%
|
|
Huitema, Alwin D.R.
The Netherlands Cancer Institute,
Netherlands
2020 Rank: 198188
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1405 out of 94611 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 198188 | 190855 |
| Total Cites | 981 | 1175 |
| H-index | 12 | 13 |
| Hm-index | 5 | 6 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 23 | 23 |
| Total Cites to Single+First Authored Papers | 14 | 15 |
| Number of Single+First+Last Authored Papers | 140 | 140 |
| Total Cites to Single+First+Last Authored Papers | 321 | 382 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 808 | 880 |
| Ratio of Total Citations to Distinct Citing Papers | 1.21 | 1.34 |
| Self-Citation Percentage |
16.51%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.